![Samuel Bjork](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel Bjork
Directeur/Membre du Conseil chez
EpiBiologics, Inc.
Profil
Samuel Bjork is currently a Director at PetMedix Ltd., Bonum Therapeutics, Inc., and EpiBiologics, Inc. He is also a Partner at Digitalis Ventures LLC.
Previously, he worked as a Strategic Advisor at Columbia Technology Ventures.
He received his undergraduate degree from Harvard University and his graduate degrees from the University of Oxford and the University of Cambridge.
Postes actifs de Samuel Bjork
| Sociétés | Poste | Début |
|---|---|---|
Digitalis Ventures LLC
 Digitalis Ventures LLC Investment ManagersFinance Digitalis Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science, health technologies & services and animal health. It participates in early stage capital requirements. | Private Equity Investor | 01/01/2017 |
Bonum Therapeutics, Inc.
 Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Directeur/Membre du Conseil | - |
EpiBiologics, Inc.
 EpiBiologics, Inc. BiotechnologyHealth Technology Develops antibodies to degrade disease causing proteins | Directeur/Membre du Conseil | 20/07/2023 |
PetMedix Ltd.
 PetMedix Ltd. BiotechnologyHealth Technology Develops therapeutic antibodies for chronic and terminal diseases pets | Directeur/Membre du Conseil | - |
Anciens postes connus de Samuel Bjork
| Sociétés | Poste | Fin |
|---|---|---|
Columbia Technology Ventures
 Columbia Technology Ventures Investment ManagersFinance Columbia Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Consultant / Advisor | 01/02/2017 |
Formation de Samuel Bjork
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Technology Ventures
Columbia Technology Ventures Investment ManagersFinance Columbia Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
Digitalis Ventures LLC
Digitalis Ventures LLC Investment ManagersFinance Digitalis Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science, health technologies & services and animal health. It participates in early stage capital requirements. | Finance |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Develops therapeutic antibodies for chronic and terminal diseases pets | Health Technology |
Bonum Therapeutics, Inc.
Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Commercial Services |
EpiBiologics, Inc.
EpiBiologics, Inc. BiotechnologyHealth Technology Develops antibodies to degrade disease causing proteins | Health Technology |
